TrialClinical pharmacology and therapeutics2021

First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19.

Peter Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.